Cargando…

Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower

BACKGROUND: Patient-reported outcomes (PROs) are increasingly used to track symptoms and to assess disease activity, quality of life, and treatment effectiveness. It is therefore important to understand which PROs patients with rheumatic and musculoskeletal disease consider most important to track f...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowell, W. Benjamin, Gavigan, Kelly, Kannowski, Carol L., Cai, Zhihong, Hunter, Theresa, Venkatachalam, Shilpa, Birt, Julie, Workman, Jennifer, Curtis, Jeffrey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873115/
https://www.ncbi.nlm.nih.gov/pubmed/33568191
http://dx.doi.org/10.1186/s13075-021-02430-0
_version_ 1783649327419228160
author Nowell, W. Benjamin
Gavigan, Kelly
Kannowski, Carol L.
Cai, Zhihong
Hunter, Theresa
Venkatachalam, Shilpa
Birt, Julie
Workman, Jennifer
Curtis, Jeffrey R.
author_facet Nowell, W. Benjamin
Gavigan, Kelly
Kannowski, Carol L.
Cai, Zhihong
Hunter, Theresa
Venkatachalam, Shilpa
Birt, Julie
Workman, Jennifer
Curtis, Jeffrey R.
author_sort Nowell, W. Benjamin
collection PubMed
description BACKGROUND: Patient-reported outcomes (PROs) are increasingly used to track symptoms and to assess disease activity, quality of life, and treatment effectiveness. It is therefore important to understand which PROs patients with rheumatic and musculoskeletal disease consider most important to track for disease management. METHODS: Adult US patients within the ArthritisPower registry with ankylosing spondylitis, fibromyalgia syndrome, osteoarthritis, osteoporosis, psoriatic arthritis, rheumatoid arthritis, and systemic lupus erythematosus were invited to select between 3 and 10 PRO symptom measures they felt were important to digitally track for their condition via the ArthritisPower app. Over the next 3 months, participants (pts) were given the option to continue tracking their previously selected measures or to remove/add measures at 3 subsequent monthly time points (month [m] 1, m2, m3). At m3, pts prioritized up to 5 measures. Measures were rank-ordered, summed, and weighted based on pts rating to produce a summary score for each PRO measure. RESULTS: Among pts who completed initial selection of PRO assessments at baseline (N = 253), 140 pts confirmed or changed PRO selections across m1–3 within the specified monthly time window (28 days ± 7). PROs ranked as most important for tracking were PROMIS Fatigue, Physical Function, Pain Intensity, Pain Interference, Duration of Morning Joint Stiffness, and Sleep Disturbance. Patient’s preferences regarding the importance of these PROs were stable over time. CONCLUSION: The symptoms that rheumatology patients prioritized for longitudinal tracking using a smartphone app were fatigue, physical function, pain, and morning joint stiffness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02430-0.
format Online
Article
Text
id pubmed-7873115
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78731152021-02-10 Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower Nowell, W. Benjamin Gavigan, Kelly Kannowski, Carol L. Cai, Zhihong Hunter, Theresa Venkatachalam, Shilpa Birt, Julie Workman, Jennifer Curtis, Jeffrey R. Arthritis Res Ther Research Article BACKGROUND: Patient-reported outcomes (PROs) are increasingly used to track symptoms and to assess disease activity, quality of life, and treatment effectiveness. It is therefore important to understand which PROs patients with rheumatic and musculoskeletal disease consider most important to track for disease management. METHODS: Adult US patients within the ArthritisPower registry with ankylosing spondylitis, fibromyalgia syndrome, osteoarthritis, osteoporosis, psoriatic arthritis, rheumatoid arthritis, and systemic lupus erythematosus were invited to select between 3 and 10 PRO symptom measures they felt were important to digitally track for their condition via the ArthritisPower app. Over the next 3 months, participants (pts) were given the option to continue tracking their previously selected measures or to remove/add measures at 3 subsequent monthly time points (month [m] 1, m2, m3). At m3, pts prioritized up to 5 measures. Measures were rank-ordered, summed, and weighted based on pts rating to produce a summary score for each PRO measure. RESULTS: Among pts who completed initial selection of PRO assessments at baseline (N = 253), 140 pts confirmed or changed PRO selections across m1–3 within the specified monthly time window (28 days ± 7). PROs ranked as most important for tracking were PROMIS Fatigue, Physical Function, Pain Intensity, Pain Interference, Duration of Morning Joint Stiffness, and Sleep Disturbance. Patient’s preferences regarding the importance of these PROs were stable over time. CONCLUSION: The symptoms that rheumatology patients prioritized for longitudinal tracking using a smartphone app were fatigue, physical function, pain, and morning joint stiffness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02430-0. BioMed Central 2021-02-10 2021 /pmc/articles/PMC7873115/ /pubmed/33568191 http://dx.doi.org/10.1186/s13075-021-02430-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Nowell, W. Benjamin
Gavigan, Kelly
Kannowski, Carol L.
Cai, Zhihong
Hunter, Theresa
Venkatachalam, Shilpa
Birt, Julie
Workman, Jennifer
Curtis, Jeffrey R.
Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower
title Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower
title_full Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower
title_fullStr Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower
title_full_unstemmed Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower
title_short Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower
title_sort which patient-reported outcomes do rheumatology patients find important to track digitally? a real-world longitudinal study in arthritispower
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873115/
https://www.ncbi.nlm.nih.gov/pubmed/33568191
http://dx.doi.org/10.1186/s13075-021-02430-0
work_keys_str_mv AT nowellwbenjamin whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower
AT gavigankelly whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower
AT kannowskicaroll whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower
AT caizhihong whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower
AT huntertheresa whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower
AT venkatachalamshilpa whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower
AT birtjulie whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower
AT workmanjennifer whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower
AT curtisjeffreyr whichpatientreportedoutcomesdorheumatologypatientsfindimportanttotrackdigitallyarealworldlongitudinalstudyinarthritispower